Clinical Trials Arena May 3, 2024
Boehringer is collaborating with EmVenio Research to introduce mobile community research units to extend the reach of trials.
Boehringer Ingelheim and US-based pharmacy store chain Walgreens have entered into a strategic partnership to optimise clinical trial recruitment and improve accessibility, inclusivity and equity.
This deal expects to use select Walgreens pharmacies as clinical trial sites for individuals with obesity, overweight, and type 2 diabetes, focusing on Phase III clinical research.
The initiative targets the dismantling of barriers to clinical trial participation, aiming to achieve equitable health representation, particularly among Black and Hispanic communities in the US.
These groups are claimed to have historically been facing underrepresentation in clinical trials and are more likely to be affected by obesity.
In addition...
Today's Sponsors
Today's Sponsor